Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.

OBJECTIVE: To identify and critically evaluate evidence from randomized controlled trials for the efficacy of treatments for mucous membrane pemphigoid (MMP)/cicatricial pemphigoid (CP) and epidermolysis bullosa acquisita (EBA). SEARCH STRATEGY: Review of MEDLINE from 1966 through March 2000, EMBAS...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Kirtschig, G, Murrell, D, Wojnarowska, F, Khumalo, N
Materyal Türü: Journal article
Dil:English
Baskı/Yayın Bilgisi: 2002
_version_ 1826298230166519808
author Kirtschig, G
Murrell, D
Wojnarowska, F
Khumalo, N
author_facet Kirtschig, G
Murrell, D
Wojnarowska, F
Khumalo, N
author_sort Kirtschig, G
collection OXFORD
description OBJECTIVE: To identify and critically evaluate evidence from randomized controlled trials for the efficacy of treatments for mucous membrane pemphigoid (MMP)/cicatricial pemphigoid (CP) and epidermolysis bullosa acquisita (EBA). SEARCH STRATEGY: Review of MEDLINE from 1966 through March 2000, EMBASE from 1980 through March 2000, and the Cochrane Controlled Trials Register (February 28, 2001) to identify randomized controlled trials for the efficacy of treatments in MMP/CP and EBA. SELECTION CRITERIA: All randomized controlled trials of therapeutic interventions that included patients with MMP/CP or EBA confirmed by immunofluorescence study findings. All age groups were included. RESULTS: We found 2 small randomized controlled trials of MMP/CP, both conducted in patients with severe eye involvement. We were not able to identify a randomized controlled trial of therapeutic interventions in EBA. CONCLUSIONS: There is evidence from 2 small trials that severe ocular CP responds best to treatment with cyclophosphamide, and mild to moderate disease seems effectively suppressed by treatment with dapsone. No treatment recommendations can be made for EBA because to our knowledge no randomized controlled trials are published. Even though systemic corticosteroids are regarded as the gold standard in the treatment of MMP/CP and EBA, there is poor evidence from the literature that they are the best treatment for these diseases.
first_indexed 2024-03-07T04:43:41Z
format Journal article
id oxford-uuid:d286634c-2144-483f-9e50-3209025cc16d
institution University of Oxford
language English
last_indexed 2024-03-07T04:43:41Z
publishDate 2002
record_format dspace
spelling oxford-uuid:d286634c-2144-483f-9e50-3209025cc16d2022-03-27T08:04:31ZInterventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d286634c-2144-483f-9e50-3209025cc16dEnglishSymplectic Elements at Oxford2002Kirtschig, GMurrell, DWojnarowska, FKhumalo, N OBJECTIVE: To identify and critically evaluate evidence from randomized controlled trials for the efficacy of treatments for mucous membrane pemphigoid (MMP)/cicatricial pemphigoid (CP) and epidermolysis bullosa acquisita (EBA). SEARCH STRATEGY: Review of MEDLINE from 1966 through March 2000, EMBASE from 1980 through March 2000, and the Cochrane Controlled Trials Register (February 28, 2001) to identify randomized controlled trials for the efficacy of treatments in MMP/CP and EBA. SELECTION CRITERIA: All randomized controlled trials of therapeutic interventions that included patients with MMP/CP or EBA confirmed by immunofluorescence study findings. All age groups were included. RESULTS: We found 2 small randomized controlled trials of MMP/CP, both conducted in patients with severe eye involvement. We were not able to identify a randomized controlled trial of therapeutic interventions in EBA. CONCLUSIONS: There is evidence from 2 small trials that severe ocular CP responds best to treatment with cyclophosphamide, and mild to moderate disease seems effectively suppressed by treatment with dapsone. No treatment recommendations can be made for EBA because to our knowledge no randomized controlled trials are published. Even though systemic corticosteroids are regarded as the gold standard in the treatment of MMP/CP and EBA, there is poor evidence from the literature that they are the best treatment for these diseases.
spellingShingle Kirtschig, G
Murrell, D
Wojnarowska, F
Khumalo, N
Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.
title Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.
title_full Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.
title_fullStr Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.
title_full_unstemmed Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.
title_short Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.
title_sort interventions for mucous membrane pemphigoid cicatricial pemphigoid and epidermolysis bullosa acquisita a systematic literature review
work_keys_str_mv AT kirtschigg interventionsformucousmembranepemphigoidcicatricialpemphigoidandepidermolysisbullosaacquisitaasystematicliteraturereview
AT murrelld interventionsformucousmembranepemphigoidcicatricialpemphigoidandepidermolysisbullosaacquisitaasystematicliteraturereview
AT wojnarowskaf interventionsformucousmembranepemphigoidcicatricialpemphigoidandepidermolysisbullosaacquisitaasystematicliteraturereview
AT khumalon interventionsformucousmembranepemphigoidcicatricialpemphigoidandepidermolysisbullosaacquisitaasystematicliteraturereview